Concepedia

Author

D. Gary Gilliland

Brigham and Women's Hospital

Also Known As

D G Gilliland, D Gary Gilliland, D Gilliland, D. G. Gilliland, D. Gary GILLILAND, D. Gary GIlliland, D. Gary Gilliland, D. Gilliland, D.G. Gilliland, D.Gary Gilliland

288

Publications

41.2K

Citations

90

H-Index

77

Concepts

All Affiliations

Brigham and Women's HospitalHarvard UniversityDana-Farber Cancer InstituteHoward Hughes Medical InstituteEmory University
DG

About

D. Gary Gilliland is an author at Brigham and Women's Hospital specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

40

44

19.6K

2

Cell Biology

33

36

18.1K

3

Health Sciences

7

7

2.8K

4

Engineering

1

1

195

5

Natural Sciences

1

1

60

D. Gary Gilliland

×

103

Publications

35.6K

Citations

77

H-Index

YearCitations

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

David A. Barbie, Pablo Tamayo, Jesse S. Boehm,

Nature

2009

4.1K

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Ross L. Levine, Martha Wadleigh, Jan Cools,

Cancer Cell

2005

3K

A Tyrosine Kinase Created by Fusion of the <i>PDGFRA</i> and <i>FIP1L1</i> Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

Jan Cools, Daniel J. DeAngelo, Jason Gotlib,

New England Journal of Medicine

2003

1.7K

FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress

Zuzana Tóthová, Ramya Kollipara, Brian J.P. Huntly,

Cell

2007

1.5K

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

Yana Pikman, Benjamin H. Lee, Thomas Mercher,

PLoS Medicine

2006

1.4K

<i>JAK2</i> Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis

Linda M. Scott, Wei Tong, Ross L. Levine,

New England Journal of Medicine

2007

1.2K

FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis

Ji-Hye Paik, Ramya Kollipara, Gerald Chu,

Cell

2007

1K

Activating mutations in ALK provide a therapeutic target in neuroblastoma

Rani E. George, Takaomi Sanda, Megan Hanna,

Nature

2008

885

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

Ayalew Tefferi, Jüergen Thiele, Attilio Orazi,

Blood

2007

857

Direct inhibition of the NOTCH transcription factor complex

Raymond E. Moellering, Melanie Cornejo, Tina Davis,

Nature

2009

748

Page 1